Aysola Jaya, Tahirovic Emin, Troxel Andrea B, Asch David A, Gangemi Kelsey, Hodlofski Amanda T, Zhu Jingsan, Volpp Kevin
1 Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
2 Center for Health Incentives and Behavioral Economics (CHIBE) at the Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
Am J Health Promot. 2018 Mar;32(3):745-752. doi: 10.1177/0890117116671673. Epub 2016 Oct 21.
To examine the effect of an opt-out default recruitment strategy compared to a conventional opt-in strategy on enrollment and adherence to a behavioral intervention for poorly controlled diabetic patients.
Randomized controlled trial.
University of Pennsylvania primary care practices.
Participants of this trial included those with (1) age 18 to 80 years; (2) diabetes diagnosis; and (3) a measured hemoglobin A1c (HbA1c) greater than 8% in the past 12 months.
We randomized eligible patients into opt-in and opt-out arms prior to enrollment. Those in the opt-out arm received a letter stating that they were enrolled into a diabetes research study with the option to opt out, and those in the opt-in arm received a standard recruitment letter.
Main end points include enrollment rate, defined as the proportion of participants who attended the baseline visit, and adherence to daily glycemic monitoring.
We powered our study to detect a 20% difference in adherence to device usage between arms and account for a 10% attrition rate.
Of the 569 eligible participants who received a recruitment letter, 496 were randomized to the opt-in arm and 73 to the opt-out arm. Enrollment rates were 38% in the opt-out arm and 13% in the opt-in arm ( P < .001).
Opt-out defaults, where clinically appropriate, could be a useful approach for increasing the generalizability of low-risk trials testing behavioral interventions in clinical settings.
比较退出式默认招募策略与传统的加入式策略对血糖控制不佳的糖尿病患者参与行为干预的招募率和依从性的影响。
随机对照试验。
宾夕法尼亚大学初级保健机构。
本试验的参与者包括:(1)年龄在18至80岁之间;(2)已确诊糖尿病;(3)在过去12个月中测得的糖化血红蛋白(HbA1c)大于8%。
在招募前,我们将符合条件的患者随机分为加入式组和退出式组。退出式组的患者收到一封信,告知他们已被纳入一项糖尿病研究,可选择退出;加入式组的患者收到标准的招募信。
主要终点包括招募率,定义为参加基线访视的参与者比例,以及每日血糖监测的依从性。
我们设定研究效力以检测两组在设备使用依从性上20%的差异,并考虑10%的损耗率。
在收到招募信的569名符合条件的参与者中,496人被随机分配到加入式组,73人被分配到退出式组。退出式组的招募率为38%,加入式组为13%(P <.001)。
在临床适用的情况下,退出式默认设置可能是一种有用的方法,可提高在临床环境中测试行为干预的低风险试验的普遍性。